Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amiko is a private digital health and medical device company focused on respiratory care. The company develops hardware-enabled, AI-powered digital medicines centered on connected inhaler sensors, patient-facing software, and provider monitoring tools. Its flagship platform, Respiro, is designed to improve medication adherence, inhaler technique, and disease control in asthma and other respiratory conditions. Amiko appears to operate through a UK legal entity and an Italian operating entity, with headquarters presence in Milan and additional activity in London. The company partners with healthcare providers and inhaler manufacturers rather than operating as a traditional therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amiko.